Your session is about to expire
← Back to Search
Cervical Mediastinoscopy for Lung Cancer (CT0030 Trial)
N/A
Recruiting
Led By Moishe Liberman, MD, PhD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-6months
Awards & highlights
CT0030 Trial Summary
This trial examines a new, minimally invasive technique to access the pleural cavity and perform pleural, pulmonary and mediastinal procedures. The technique, called C-VATS, is a safe and feasible option for patients with pleural disease or effusion.
Who is the study for?
This trial is for adults with pleural disease or effusion who need a biopsy, drainage, or pleurodesis and are suitable for VATS. It's not for those under 18, pregnant women, patients with prior mediastinal irradiation, on non-stop anticoagulants like Warfarin, with neck infections/inability to extend the neck fully, cervical spine instability, or past surgeries that rule out mediastinoscopy.Check my eligibility
What is being tested?
C-VATS is being tested as a less invasive way to access the chest cavity and perform procedures on the lungs and surrounding areas. This study will see if it's feasible and safe to use C-VATS for evaluating lung conditions and performing biopsies or treatments like pleurodesis.See study design
What are the potential side effects?
While specific side effects of C-VATS aren't listed here, similar procedures may cause pain at the incision site, bleeding, infection risk post-operation and potential complications related to anesthesia.
CT0030 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-6months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-6months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
procedure-related morbidity
Secondary outcome measures
Procedural, hospitalization and overall cost
pain related to technique
CT0030 Trial Design
1Treatment groups
Experimental Treatment
Group I: Single group assignmentExperimental Treatment1 Intervention
Cervical mediastinoscopy
Find a Location
Who is running the clinical trial?
Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
366 Previous Clinical Trials
129,627 Total Patients Enrolled
Moishe Liberman, MD, PhDPrincipal InvestigatorCentre de Recherche du Centre Hospitalier de l'Université de Montréal
16 Previous Clinical Trials
1,221 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had radiation therapy to the chest area before.I am a candidate for a specific lung procedure using a minimally invasive technique.I am on blood thinners that cannot be stopped.I am under 18 years old.I have an active infection in my neck area.I have been diagnosed with mediastinitis before.My neck bones are not stable.I cannot fully extend my neck.I've had neck or chest surgery that prevents further procedures.
Research Study Groups:
This trial has the following groups:- Group 1: Single group assignment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger